NCT03660865View on ClinicalTrials.gov

Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

August 28, 2018

Primary Completion Date

April 1, 2020

Study Completion Date

April 1, 2020

Conditions
AphakiaCataract
Interventions
DEVICE

Light Adjustable lens (LAL) and Light Delivery Device (LDD)

Primary eye will receive Light adjustable lens with Light delivery Device treatments

DEVICE

Control IOL

Fellow eye will receive control IOL

Trial Locations (6)

44141

Cleveland Eye Clinic, Brecksville

57108

Vance Thompson Vision Clinic, Sioux Falls

66211

Discover Vision Centers, Leawood

77027

Slade & Baker Vision, Houston

78229

Focal Point Vision, San Antonio

84107

The Eye Institute of Utah, Salt Lake City

All Listed Sponsors
lead

RxSight, Inc.

INDUSTRY

NCT03660865 - Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery | Biotech Hunter | Biotech Hunter